Back to search
Atresia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atresia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atresia trials you may qualify forThis study aims to investigate how different types and intensities of exercise affect muscle recovery in individuals taking statin medications compared to healt…
Esophageal atresia (EA) is one of the most common gastrointestinal congenital anomalies that affects 1 in 2500 to 1 in 4000 live births. It is characterized by…
Oesophageal atresia (OAEA), a malformation of the oesophagus present from birth, is characterized by the interruption of the continuity of the oesophagus, which…
Biliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-inva…
This study is a prospective, single center and observational open clinical study.
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (t…
Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary at…
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia